Navigation Links
ISTA Pharmaceuticals Announces Results of Clinical Trial of Xibrom(TM) QD (Once-Daily) Formulation
Date:4/1/2008

="http://www.istavision.com" target="_new">http://www.istavision.com.

Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements. Without limiting the foregoing, but by way of example, statements contained in this press release related to the completion of the data analysis and discussions with the FDA regarding the Xibrom QD NDA or possible new Xibrom products and the possibility of a label change for the currently marketed 0.09% formulation of Xibrom, bringing a new product to market every 12 to 18 months, and becoming the leading niche ophthalmic pharmaceutical company are forward- looking statements. Except as required by law, ISTA disclaims any intent or obligation to update any forward-looking statements. These forward-looking statements are based on ISTA's expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially. Important factors that could cause actual results to differ from current expectations include, among others: timely and successful implementation of ISTA's strategic initiatives; delays and uncertainties related to ISTA's research and development programs (including the difficulty of predicting the timing or outcome of product development efforts and the FDA or other regulatory agency approval or actions); uncertainties and risks regarding market acceptance of and demand for ISTA's approved products and the impact of competitive products and pricing; uncertainties and risks related to ISTA's ability to properly manage its growth; uncertainties and risks regarding the continued timely performance by ISTA's strategic partners of their respective obligations under existing collaborations and licensing arrangements; uncertainties and risks related to the continued availability of third party sourced products and raw materials on commercially reasonable terms, or at all; uncertai
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
2. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
3. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
4. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
5. Anacor Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial of AN2728 in Psoriasis Patients
6. NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204
7. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
8. VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial
9. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
10. BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM)
11. Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... TEANECK, N.J. , May 21, 2013 /PRNewswire-iReach/ ... 17-19 in NJ has attracted the greatest number ... reports its President, Mark Alexay ... "But suddenly everyone plans to attend this year.  The show,s still ... of different companies.  This is a big surprise ...
(Date:5/21/2013)... 2013  IsoRay, Inc. (AMEX: ISR ), ... into an exclusive international distribution agreement with IASIS Medical ... Greece . IsoRay is a medical ... radioisotope applications for brain cancer, lung cancer, head and ... IASIS Medical is ideally suited to support ...
(Date:5/21/2013)... 2013  The North Shore-LIJ Health System is expanding ... compliance at North Shore University Hospital in ... rooms at Forest Hills (NY) ... The new pilot program strengthens patient safety by providing ... the first time in the US that remote video ...
Breaking Medicine Technology:Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2IsoRay Announces A New International Distributor For Greece 2IsoRay Announces A New International Distributor For Greece 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4
... 2011 Reportlinker.com announces that a new market ... Global Ophthalmic Instrumentation Industry ... This report analyzes the worldwide markets for Ophthalmic ... by the following segments: Diagnostic Devices (Perimeters, Refractors, ...
... FREMONT, Calif., Feb. 2, 2011 WaferGen Biosystems, Inc. ... state-of-the-art genomic analysis systems, today announced that it will present an ... Investor Conference in New York City at the Waldorf Astoria Hotel, ... will be webcast live and archived for 90 days and may ...
Cached Medicine Technology:Global Ophthalmic Instrumentation Industry 2Global Ophthalmic Instrumentation Industry 3Global Ophthalmic Instrumentation Industry 4Global Ophthalmic Instrumentation Industry 5Global Ophthalmic Instrumentation Industry 6Global Ophthalmic Instrumentation Industry 7Global Ophthalmic Instrumentation Industry 8Global Ophthalmic Instrumentation Industry 9Global Ophthalmic Instrumentation Industry 10Global Ophthalmic Instrumentation Industry 11Global Ophthalmic Instrumentation Industry 12Global Ophthalmic Instrumentation Industry 13Global Ophthalmic Instrumentation Industry 14Global Ophthalmic Instrumentation Industry 15Global Ophthalmic Instrumentation Industry 16Global Ophthalmic Instrumentation Industry 17Global Ophthalmic Instrumentation Industry 18Global Ophthalmic Instrumentation Industry 19Global Ophthalmic Instrumentation Industry 20Global Ophthalmic Instrumentation Industry 21Global Ophthalmic Instrumentation Industry 22Global Ophthalmic Instrumentation Industry 23Global Ophthalmic Instrumentation Industry 24Global Ophthalmic Instrumentation Industry 25WaferGen to Present at 13th Annual BIO CEO and Investor Conference 2
(Date:5/21/2013)... Feed additives have now become an ... chain. Most of the feed additives are used in ... and powders. There are variety of feed additives available ... upon the type of animal and feed. Nutritional feed ... essential nutrition to the animal in order to gain ...
(Date:5/21/2013)... Patients of Dr. Michael Shenk and Dr. Judd Shenk ... gum disease and would like permanent tooth replacements now have ... laser gum surgery. Gum disease must be treated prior ... of all tooth replacement options. , The Laser Assisted ... by the Food and Drug Administration (FDA) that greatly improves ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 ContinuCare Home ... Texas Department of Aging and Disability Services. After completing ... employee interviews, ContinuCare Home Health was found to ... review is part of the Department of Aging and ... aging and disability services, supports and opportunities that ...
(Date:5/21/2013)... 2013, Paris, France: One-year results from SOURCE XT ... (TAVI) registries to-date reported today at EuroPCR 2013 ... high rates of device success for all access approaches, ... Post-Approval Study followed up 2688 consecutively enrolled patients (mean ... heart valve at 93 centres in 17 countries between ...
(Date:5/21/2013)... 2013 The In View series ... and cable channels across the country, announces it has ... channel. The producers of the series proudly bring audiences ... industry, the manufacturing industry, health-related companies, medical facilities and ... medical practitioners in all parts of the United States, ...
Breaking Medicine News(10 mins):Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 2Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 3Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 4Health News:Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA 2Health News:ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services 2Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2
... out that certain ordinary drugs like//anti-psychotic and gastro-intestinal drugs ... study, which was published in the European Heart Journal, ... activity controlling heartbeats that can increase the risk of ... can prolong the duration of electrical activity that controls ...
... Harvard Medical School have reported that birth weight and// adult ... of coronary heart disease. ,Over 66,000 female nurses were ... ,The results of the research show that higher the ... chance of having coronary heart disease. For each kg increase ...
... Hospital, Boston, US, have reported that a diet// with low ... cardiovascular disease than the conventional low fat diet. ,A ... Glycemic Index (GI) ranks foods on their effect on the ... Some food items raise the blood glucose level more than ...
... US had approved the first test that// uses DNA in blood ... Fibrosis Kit and it can analyze DNA samples from the blood ... in children and in adults. The test can not only predict ... identify the people who are not having the disease but are ...
... A drink a day may reduce the risk of kidney ... males, who had moderate consumption of alcohol weekly (about a ... reduced glomerular filtration rates with men who drank less than ... the drinking pattern and renal function of these men through ...
... biomarker for prostate cancer cells do// that it will become ... was hidden inside the cells, can now be moved to ... blood. This will make it possible for the medical professionals ... immunotherapy, for better and more effective way to kill the ...
Cached Medicine News:
Straight shafts with rounded tips. Smooth handle with dull finish....
15 mm curved blade. 8 mm straight distal tip. Serrated on top of knife. Flat handle....
8 mm curved blade. Cutting edge on inside of curve. Flat handle....
... mm long blade. 17 mm ... mm, 12.0 inches. Note: Has ... left-hand cutting to any thickness ... mm). For thicker grafts or ...
Medicine Products: